-A +A

Error message

Deprecated function: The each() function is deprecated. This message will be suppressed on further calls in _menu_load_objects() (line 569 of /home/tlceye5/public_html/www.kevinlaverymd.com/includes/menu.inc).

Research

Dr. Lavery participates in clinical trials allowing him to offer cutting edge treatment to patients in a study atmosphere. We are very honored to participate in these studies and are excited about the contribution they will make to future treatments in ophthalmology and patient care.

  • Principal Investigator; Bausch & Lomb Inc.
    A Prospective, Multicenter Clinical Trial to evaluate the safety and effectiveness of the enVista® One-Piece Hydrophobic Acrylic Toric IOL designed to reduce the effects of preoperative corneal astigmatism on postoperative refraction following cataract surgery
    Protocol 761
    March 2013-present

  • Principal Investigator; Alcon Research Ltd.
    Nepafenac QD for ME – Randomized, Double-Masked, Vehicle Controlled, clinical evaluation to assess the safety and efficacy of nepafenac ophthalmic suspension, 0.3% for improvement in clinical outcomes among diabetic subjects following cataract surgery
    Protocol C12-067
    November 2013-present

  • Principal Investigator; Bausch & Lomb Inc
    A Prospective Multicenter Clinical Study to Evaluate the Safety and Effectiveness of a Bausch + Lomb One-Piece Hydrophobic Acrylic Intraocular Lens in Subjects Undergoing Cataract Extraction
    PROTOCOL #658
    December 2010-August 2011

  • Principal Investigator; Advanced Vision Science, Inc
    AMO Clariflex Acrylic Foldable IOL;.- AVS Foldable Intraocular Lens. Sunrise Technology; Laser Thermal Keratoplasty

  • Sub-Investigator; TearScience
    Randomized Clinical Trial for Treatment of Meibomian Gland Dysfunction and Evaporative Dry Eye
    Protocol LF-001
    February 2009-July 2009